Gut microbiota and metabolites may influence autoimmune thyroid disease, thyroid dysfunction, and thyroid cancer

Photo by Navy Medicine / Unsplash

Frontiers in Medicine Published May 28, 2026 Medically reviewed May 28, 2026 Study authors: Chao Jia, Min Li, Xianqiang Yu DOI ↗ By Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

Key Takeaway

Consider the preliminary evidence on gut microbiota's role in thyroid disease as a basis for future research, not current practice.

This is a narrative review examining the role of gut microbiota and its metabolites, including short-chain fatty acids, secondary bile acids, and lipopolysaccharides, in autoimmune thyroid diseases, thyroid dysfunction, and thyroid cancer. The authors synthesize existing evidence to argue that the gut microbiome may influence thyroid health, potentially through immune modulation and metabolic pathways. The review does not report specific study populations, sample sizes, or quantitative effect sizes. Key arguments focus on the potential for microbiota-targeted interventions like probiotics, prebiotics, and dietary modifications as adjunctive strategies in thyroid disease management. The authors acknowledge significant gaps in the evidence, including a lack of reported clinical trial data, defined follow-up periods, or safety outcomes. Practice relevance is framed cautiously, noting that while microbiota modulation is a promising area, current evidence is insufficient to support specific clinical recommendations. The review highlights the need for more rigorous research to establish causality and define therapeutic applications.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedMay 2026

View Original Abstract ↓

The gut microbiota, a complex and dynamic ecosystem of microorganisms residing in the gastrointestinal tract, has emerged as a critical regulator of human physiology, extending its influence far beyond digestion. Recent advances have illuminated the existence of a bidirectional communication network known as the “gut-thyroid axis” which posits that the intestinal microbial community and its vast repertoire of bioactive metabolites are fundamental modulators of thyroid health and disease pathogenesis. This comprehensive academic review synthesizes current evidence to elucidate the multifaceted functions and mechanisms through which gut microbiota and its metabolites, such as short-chain fatty acids, secondary bile acids, and lipopolysaccharides, impact thyroid disorders. We detail how these microbial components regulate systemic immunity, influence thyroid hormone metabolism, maintain intestinal barrier integrity, and modulate nutrient absorption, thereby contributing to the development and progression of autoimmune thyroid diseases, thyroid dysfunction, and potentially thyroid cancer. Furthermore, the review discusses the translational implications of this knowledge, including the potential for microbiota-targeted interventions like probiotics, prebiotics, and dietary modifications as adjunctive strategies in thyroid disease management. By integrating findings from human studies and animal models, this review aims to provide a mechanistic framework for understanding the gut-thyroid connection and to highlight promising avenues for future research and precision medicine approaches in endocrinology.